WARNING: “Buffett Indicator” flashing for first time in 50 years

Warren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indicates the Oracle of Omaha is quietly preparing for a historic market crash. His most reliable crash indicator - the "Buffett indicator" - just flashed red for the first time in 25 years.

Take these 4 steps today to protect your retirement NOW

Greg D. Carmichael net worth and biography

Greg Carmichael Biography and Net Worth

Director of Encompass Health

Mr. Carmichael retired as the executive chairman of Fifth Third Bancorp in April 2023. He joined Fifth Third in June 2003 as executive vice president and chief information officer. After being named chief operating officer in 2006, he became president in 2012. He was appointed to Fifth Third’s board of directors and became CEO in 2015 and was elected chairman of the board in 2018. In July 2022, Mr. Carmichael stepped down as CEO and became executive chairman of Fifth Third Bancorp. From 2000 to 2003, Mr. Carmichael was vice president and chief information officer for Emerson Electric, a worldwide provider of technology and energy solutions. From 1996 to 2000, he served in the same roles for a subsidiary of Emerson, and from 1986 to 1996, he served in several information technology and leadership roles at General Electric.

What is Greg D. Carmichael's net worth?: The estimated net worth of Greg D. Carmichael is at least $1.61 million as of May 3rd, 2024. Mr. Carmichael owns 17,050 shares of Encompass Health stock worth more than $1,610,373 as of December 21st. This net worth evaluation does not reflect any other investments that Mr. Carmichael may own. Learn More about Greg D. Carmichael's net worth.
How do I contact Greg D. Carmichael?: The corporate mailing address for Mr. Carmichael and other Encompass Health executives is 3660 Grandview Pkwy Ste 200, BIRMINGHAM, AL 35243-3332, United States. Encompass Health can also be reached via phone at (205) 967-7116 and via email at [email protected]. Learn More on Greg D. Carmichael's contact information.
Has Greg D. Carmichael been buying or selling shares of Encompass Health?: Greg D. Carmichael has not been actively trading shares of Encompass Health over the course of the past ninety days. Most recently, on Friday, May 3rd, Greg D. Carmichael bought 2,000 shares of Encompass Health stock. The stock was acquired at an average cost of $83.73 per share, with a total value of $167,460.00. Following the completion of the transaction, the director now directly owns 17,050 shares of the company's stock, valued at $1,427,596.50. Learn More on Greg D. Carmichael's trading history.
Who are Encompass Health's active insiders?: Encompass Health's insider roster includes Greg Carmichael (Director), Elissa Charbonneau (Insider), Douglas Coltharp (CFO), John Darby (EVP,General Counsel & Corporate Secretary), Kevin O'Connor (Director), Andrew Price (CAO), Mark Tarr (CEO, President & Director), and Terrance Williams (Director). Learn More on Encompass Health's active insiders.
Are insiders buying or selling shares of Encompass Health?: In the last year, Encompass Health insiders bought shares 1 times. They purchased a total of 2,000 shares worth more than $167,460.00. In the last year, insiders at the sold shares 4 times. They sold a total of 81,779 shares worth more than $6,874,619.34. The most recent insider tranaction occured on August, 13th when CFO Douglas E Coltharp sold 12,260 shares worth more than $1,058,528.40. Insiders at Encompass Health own 2.1% of the company. Learn More about insider trades at Encompass Health.
Information on this page was last updated on 8/13/2024.

Greg D. Carmichael Insider Trading History at Encompass Health

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
5/3/2024	Buy	2,000	$83.73	$167,460.00	17,050
10/31/2022	Buy	1,830	$54.67	$100,046.10	10,546

Greg D. Carmichael Buying and Selling Activity at Encompass Health

Encompass Health Company Overview

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions. It offers services through the Medicare program to federal government, managed care plans and private insurers, state governments, and other patients. The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. The company was incorporated in 1984 and is based in Birmingham, Alabama.

Today's Range

Now: $94.45

$93.73

$95.19

50 Day Range

MA: $99.47

$93.13

$103.77

2 Week Range

Now: $94.45

$65.96

$104.55

Volume

1,396,933 shs

Average Volume

644,411 shs

Market Capitalization

$9.52 billion

P/E Ratio

22.81

Dividend Yield

0.72%

Beta

0.86